Soft Tissue Sarcoma (Excluding GIST)
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Soft Tissue Sarcoma (Excluding GIST)?
There are 1 clinical trial targeting Soft Tissue Sarcoma (Excluding GIST) tracked by BioSniper.
What is the prevalence of Soft Tissue Sarcoma (Excluding GIST)?
The estimated prevalence of Soft Tissue Sarcoma (Excluding GIST) is approximately 30.0 per 100,000 population.
Deep-dive into Soft Tissue Sarcoma (Excluding GIST)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis